© 2023 MJH Life Sciences and Urology Times. All rights reserved.
© 2023 MJH Life Sciences™ and Urology Times. All rights reserved.
January 04, 2023
“Each unit of blood that you got during surgery was associated with about 7% higher odds of a VTE within 90 days,” says Timothy D. Lyon, MD, FACS.
January 02, 2023
"I think NAI plus BCG will be a game-changer in the community, probably more than it would be in academic medical settings," says Karim Chamie, MD.
December 25, 2022
As the year comes to a close, we revisit some of this year’s top content on bladder cancer.
December 23, 2022
"The previous group who had looked at this saw a 15% adherence to the AUA guidelines up to 2013. We're doing better, but not much better," says Megan Prunty, MD.
December 22, 2022
Dr Chamie shares advice for community urologists treating patients with MIBC.
Karim Chamie, MD, explains how he might approach immunotherapy in patients with MIBC if it were available for use in both the neoadjuvant and adjuvant settings in the future.
Dr Chamie comments on the significant unmet needs and clinical challenges in the management of MIBC.
Karim Chamie, MD, presents the case of a 77-year-old patient with T2N0M0 MIBC and the potential treatment regimen he would suggest.
Dr Chamie describes how he coordinates with medical oncologists after a referral for MIBC, and his strategies for following up with patients.
Karim Chamie, MD, reviews the currently available adjuvant therapy options for patients with stage II or III MIBC who received a cystectomy, and whether he would have treated the patient in the presented case or referred her to a medical oncologist.